From Medscape Diabetes & Endocrinology

Coverage From The

American Diabetes Association (ADA) 79th Scientific Sessions

June 07 - 11, 2019; San Francisco, CA

June 07 - 11, 2019 San Francisco, CA

ADA 2019 Early Onset Type 1 Diabetes May Affect Brain Development in Kids The decrements are linked to hyperglycemia, suggesting the recommended HbA1c target of < 7.5% in children may be too lenient.
Medscape Medical News, June 24, 2019
ADA 2019 CREDENCE 'Knocks Your Socks Off'; New Analysis Reported at ADA Latest analysis of CREDENCE with SGLT2 inhibitor canagliflozin shows the agent has a cardio- and renal-protective effect in both primary and secondary CV prevention populations.
Medscape Medical News, June 17, 2019
ADA 2019 CV Benefit of Newer Type 2 Diabetes Drugs Not Seen in Black Patients In cardiovascular outcomes trials for type 2 diabetes drugs, data weren't significant for benefit among the small number of black and African American participants.
Medscape Medical News, June 17, 2019

Meeting Highlights At A Glance

Top News From ADA 2019: Slideshow Highlights include highly anticipated cardiovascular outcomes with dulaglutide, linagliptin, dapagliflozin, and oral semaglutide, and new cardiorenal data for canagliflozin.

Conference News

ADA 2019 PIONEER 5: Oral Semaglutide for Diabetes With Moderate CKD
Medscape Medical News, June 24, 2019
ADA 2019 Early Onset Type 1 Diabetes May Affect Brain Development in Kids
Medscape Medical News, June 24, 2019
ADA 2019 Diabetes Survival Skills Welcomed by Those Leaving Prison
Medscape Medical News, June 21, 2019
ADA 2019 CARMELINA: Linagliptin Safe in Diabetes Across Age, Renal Groups
Medscape Medical News, June 19, 2019
ADA 2019 New Statement on 'Time in Range' Targets for CGM Use in Diabetes
Medscape Medical News, June 18, 2019
ADA 2019 CGM During Type 1 Diabetes Pregnancy Makes Substantial Cost Savings Over Fingerprick Testing
Medscape News UK, June 18, 2019
ADA 2019 CREDENCE 'Knocks Your Socks Off'; New Analysis Reported at ADA
Medscape Medical News, June 17, 2019
ADA 2019 CV Benefit of Newer Type 2 Diabetes Drugs Not Seen in Black Patients
Medscape Medical News, June 17, 2019
ADA 2019 High BP and HbA1c: Similar Risks for CVD in Youth With Type 1 Diabetes
Medscape Medical News, June 13, 2019
ADA 2019 Large UK Audit of FreeStyle Libre: Improved HbA1c, Marked Drop in Admissions
Medscape News UK, June 13, 2019
ADA 2019 PIONEER 6: Will Oral Semaglutide Live Up to Promise in Real World?
Medscape Medical News, June 11, 2019
ADA 2019 CAROLINA Reassures on CV Safety for Linagliptin, Glimepiride in T2D
Medscape Medical News, June 11, 2019
ADA 2019 Little Difference With Oral Semaglutide vs Liraglutide in Diabetes
Medscape Medical News, June 11, 2019
ADA 2019 More DECLARE-TIMI: Robust Renal Effects of Dapagliflozin
Medscape Medical News, June 11, 2019

ADA 2019 Once-Weekly Dulaglutide Benefit in REWIND, Longest CVOT to Date
Medscape Medical News, June 10, 2019
ADA 2019 'Like Watching a Car Crash in Slow Motion': New RISE Data
Medscape Medical News, June 10, 2019
ADA 2019 Game Changer: Antibody First to Delay Type 1 Diabetes Onset in TrialNet
Medscape Medical News, June 10, 2019
ADA 2019 'Remarkable' Findings From Da Qing Diabetes Prevention Trial
Medscape Medical News, June 10, 2019
ADA 2019 Liraglutide Preserves Beta-Cell Function in New Type 1 Diabetes
Medscape Medical News, June 9, 2019
ADA 2019 'Mix and Match' Options Emerging in Automated Insulin Delivery
Medscape Medical News, June 9, 2019
ADA 2019 'Alarming' Complications in 20-Year-Olds With Type 2 Diabetes
Medscape Medical News, June 9, 2019
ADA 2019 Type 2 Diabetes Message 'Has Got to Be Trashed,' Says DiRECT Author
Medscape Medical News, June 8, 2019
ADA 2019 Implementing ACP Diabetes Guidelines Could Be Cost-Effective
Medscape Medical News, June 8, 2019
ADA 2019 More Anti-Obesity Drugs for Teens Coming, Devices Are Next Step
Medscape Medical News, June 8, 2019
ADA 2019 D2d: Vitamin D Doesn't Stop Diabetes in Those With Prediabetes
Medscape Medical News, June 7, 2019
Alert ADA 2019 Avoid Fingersticks for Diabetes Dosing Decisions With Eversense
FDA Approvals, June 7, 2019
ADA 2019 Heart (and Kidneys) Feature in Diabetes Trials in San Francisco
Medscape Medical News, May 29, 2019

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

'No Difference Between the Diets' in Reversing Prediabetes
Ian MacDonald, PhD; Mark Harmel, MPH
'None of Them Survived': Diabetes in the Time of Humanitarian Crises
Sylvia Kehlenbrink, MD; Mark Harmel, MPH
The RISE Study: Where Do We Go From Here?
Steven E. Kahn, MBChB
How to Use Ketogenic Diets in Patients With Type 2 Diabetes
Jay H. Shubrook, DO; Rucha J. Mehta, MD
CKD and CVD Hit Healthcare Pocketbook and Patients With T2D Hard
Gregory A. Nichols, PhD
Reducing Kidney and CV Complications in Diabetes
Anne L. Peters, MD; Peter Rossing, MD, DMSc
Fournier Gangrene, Genitourinary Infection With SGLT2i: ADA 2019
Tricia Ward
Soda Tax Has a 'Big Impact' on Consumption of Sugar-Sweetened Beverages
Jen Falbe, DSc, MPH; Mark Harmel, MPH
How Do the Renal Data From CREDENCE and CARMELINA Compare?
Meg J. Jardine, MBBS, PhD; Christoph Wanner, MD
Youth-Onset Type 2 Diabetes 'Needs Aggressive Intervention'
Philip S. Zeitler, MD, PhD; Mark Harmel, MPH
Vitamin D and Diabetes: What We Learned From the D2d Trial
Anastassios G. Pittas, MD, MS;
Jay H. Shubrook, DO
'Poised on a Paradigm Shift': The REWIND and DECLARE Trials
Harpreet S. Bajaj, MD, MPH; Akshay B. Jain, MD
The Latest on Hypoglycaemia Risks From ADA
Prof Simon Heller, BA, MB, Bchir, DM, FRCP
3 Cool Things to Know About Obesity: ADA 2019 Poster Pearls
Laurie Scudder, DNP, NP
Caution Urged on Use of Opioids for Diabetic Neuropathy
Dr Andrew J.M. Boulton, DSc, FRCP

Popular News from ADA 2018

New ADA/EASD Guidance on Diabetes: Assess CV Status First An upcoming document from the ADA and EASD will advise that selection of type 2 diabetes drug should be based on comorbidities and patient preferences.
Medscape Medical News, Jun 29, 2018
Implantable Glucose Sensor Bests Competitors in Head-to-Head In a real-world comparison, the Senseonics Eversense CGM was more accurate than the Dexcom G5, and both were more accurate than the Abbott FreeStyle Libre Pro.
Medscape Medical News, Jun 23, 2018
Love Affair With Metformin: Still Strong, or Time to Move On? Should metformin remain first line for the treatment of type 2 diabetes or not? That was the question. Passions were high during this entertaining debate in one of the first sessions at ADA this year.
Medscape Medical News, Jun 23, 2018
VADT at 15 Years: No Legacy Effect From Intensive HbA1c Control This 'tells us that there is a benefit of more versus less intense glucose lowering, which doesn't last forever,' and shows the importance of individualized glycemic therapy in diabetes, says a trialist.
Medscape Medical News, Jun 28, 2018
Very High HbA _1c Falls Most With GLP-1 Agonist Plus Basal Insulin In the first randomized trial to compare two strategies for patients with uncontrolled type 2 diabetes and very high HbA1c, basal insulin plus a GLP-1 receptor agonist was superior to basal-bolus insulin.
Medscape Medical News, Jul 04, 2018

Previous Coverage